AstraZeneca Plans to Double Covid-19 Vaccine Output

AstraZeneca PLC said it was fixing problems with the manufacturing of its Covid-19 vaccine and expects to roughly double monthly production to 200 million doses by April, as it seeks to move past a rocky start to the shot’s rollout. The Anglo-Swedish drugmaker reported strong full-year earnings and forecast increased 2021 earnings growth. The forecast doesn’t factor in sales of the pandemic vaccine it developed alongside the University of Oxford.